Cargando…

Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors

Mesothelin (MSLN) represents an attractive molecule for targeted cancer therapies. To identify tumors that might benefit from such therapies, tissue microarrays including 15,050 tumors from 122 different tumor types and 76 healthy organs were analyzed for MSLN expression by immunohistochemistry. Six...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weidemann, Sören, Gagelmann, Pauline, Gorbokon, Natalia, Lennartz, Maximilian, Menz, Anne, Luebke, Andreas M., Kluth, Martina, Hube-Magg, Claudia, Blessin, Niclas C., Fraune, Christoph, Möller, Katharina, Bernreuther, Christian, Lebok, Patrick, Clauditz, Till S., Jacobsen, Frank, Izbicki, Jakob R., Jansen, Kristina, Sauter, Guido, Uhlig, Ria, Wilczak, Waldemar, Steurer, Stefan, Minner, Sarah, Burandt, Eike, Krech, Rainer H., Dum, David, Krech, Till, Marx, Andreas H., Simon, Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067734/ https://www.ncbi.nlm.nih.gov/pubmed/33917081 http://dx.doi.org/10.3390/biomedicines9040397

Ejemplares similares

High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer
por: Weidemann, Sören, et al.
Publicado: (2023)

Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications
por: Völkel, Cosima, et al.
Publicado: (2021)

Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors
por: Menz, Anne, et al.
Publicado: (2021)

Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors
por: Dum, David, et al.
Publicado: (2022)

Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumors
por: Reiswich, Viktor, et al.
Publicado: (2021)

Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas
por: Uhlig, Ria, et al.
Publicado: (2022)

E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors
por: Burandt, Eike, et al.
Publicado: (2021)

Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 Tumors
por: Viehweger, Florian, et al.
Publicado: (2022)

FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors
por: Dum, David, et al.
Publicado: (2022)

Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular Carcinoma
por: Lennartz, Maximilian, et al.
Publicado: (2021)

CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas
por: Uhlig, Ria, et al.
Publicado: (2023)

Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary Gland
por: Gorbokon, Natalia, et al.
Publicado: (2023)

Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors
por: Menz, Anne, et al.
Publicado: (2022)

Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid
por: Lennartz, Maximilian, et al.
Publicado: (2023)

Napsin A Expression in Human Tumors and Normal Tissues
por: Weidemann, Sören, et al.
Publicado: (2021)

p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors
por: Steurer, Stefan, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 Tumours
por: Meiners, Jan, et al.
Publicado: (2021)

High prevalence of p16 staining in malignant tumors
por: De Wispelaere, Noémi, et al.
Publicado: (2022)

PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples
por: Möller, Katharina, et al.
Publicado: (2023)

Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells
por: Lennartz, Maximilian, et al.
Publicado: (2022)

Prognostic role of proliferating CD8(+) cytotoxic Tcells in human cancers
por: Blessin, Niclas C., et al.
Publicado: (2021)

MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue Samples
por: Rico, Sebastian Dwertmann, et al.
Publicado: (2021)

Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 Tumors
por: Weidemann, Sören, et al.
Publicado: (2022)

Prevalence of CD8(+) cytotoxic lymphocytes in human neoplasms
por: Blessin, Niclas C., et al.
Publicado: (2020)

DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness
por: Jansen, Kristina, et al.
Publicado: (2021)

Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence
por: Dum, David, et al.
Publicado: (2022)

Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma
por: Dwertmann Rico, Sebastian, et al.
Publicado: (2022)

Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer
por: Blessin, Niclas C., et al.
Publicado: (2019)

Expression of the immune checkpoint receptor TIGIT in seminoma
por: Hinsch, Andrea, et al.
Publicado: (2019)

Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues
por: Tribian, Laura Sophie, et al.
Publicado: (2023)

Expression of the immune checkpoint receptor TIGIT in Hodgkin’s lymphoma
por: Li, Wenchao, et al.
Publicado: (2018)

BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1–driven Immune Phenotypes with Distinct Spatial Orchestration
por: Bady, Elena, et al.
Publicado: (2023)

Elevated MUC5AC expression is associated with mismatch repair deficiency and proximal tumor location but not with cancer progression in colon cancer
por: Rico, Sebastian Dwertmann, et al.
Publicado: (2020)

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy()
por: Minner, Sarah, et al.
Publicado: (2019)

Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions
por: Bernreuther, Christian, et al.
Publicado: (2020)

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer
por: Weidemann, Sören A., et al.
Publicado: (2019)

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion
por: Fraune, Christoph, et al.
Publicado: (2020)

Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma
por: Eichenauer, Till, et al.
Publicado: (2020)

Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers
por: Möller, Katharina, et al.
Publicado: (2020)

Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion
por: Steurer, Stefan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n7jot6e001t2lhgm1857j6l1pt